These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 21907095
1. Pathogenic mechanisms in Huntington's disease. Jones L, Hughes A. Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095 [Abstract] [Full Text] [Related]
2. Mechanisms of neuronal cell death in Huntington's disease. Sawa A, Tomoda T, Bae BI. Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190 [Abstract] [Full Text] [Related]
10. Huntington's disease. Roze E, Bonnet C, Betuing S, Caboche J. Adv Exp Med Biol; 2010 May 03; 685():45-63. PubMed ID: 20687494 [Abstract] [Full Text] [Related]
11. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice. Kovalenko M, Dragileva E, St Claire J, Gillis T, Guide JR, New J, Dong H, Kucherlapati R, Kucherlapati MH, Ehrlich ME, Lee JM, Wheeler VC. PLoS One; 2012 May 03; 7(9):e44273. PubMed ID: 22970194 [Abstract] [Full Text] [Related]
12. Experimental models of HD and reflection on therapeutic strategies. Kim J, Bordiuk OL, Ferrante RJ. Int Rev Neurobiol; 2011 May 03; 98():419-81. PubMed ID: 21907096 [Abstract] [Full Text] [Related]
13. The use of transgenic and knock-in mice to study Huntington's disease. Hickey MA, Chesselet MF. Cytogenet Genome Res; 2003 May 03; 100(1-4):276-86. PubMed ID: 14526189 [Abstract] [Full Text] [Related]
14. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain. Liu W, Chaurette J, Pfister EL, Kennington LA, Chase KO, Bullock J, Vonsattel JP, Faull RL, Macdonald D, DiFiglia M, Zamore PD, Aronin N. J Huntingtons Dis; 2013 May 03; 2(4):491-500. PubMed ID: 25062733 [Abstract] [Full Text] [Related]
15. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Shelbourne PF, Keller-McGandy C, Bi WL, Yoon SR, Dubeau L, Veitch NJ, Vonsattel JP, Wexler NS, US-Venezuela Collaborative Research Group, Arnheim N, Augood SJ. Hum Mol Genet; 2007 May 15; 16(10):1133-42. PubMed ID: 17409200 [Abstract] [Full Text] [Related]
16. Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin. Hackam AS, Hodgson JG, Singaraja R, Zhang T, Gan L, Gutekunst CA, Hersch SM, Hayden MR. Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1047-55. PubMed ID: 10434304 [Abstract] [Full Text] [Related]
17. Selective degeneration in YAC mouse models of Huntington disease. Van Raamsdonk JM, Warby SC, Hayden MR. Brain Res Bull; 2007 Apr 30; 72(2-3):124-31. PubMed ID: 17352936 [Abstract] [Full Text] [Related]
18. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. Weiss A, Klein C, Woodman B, Sathasivam K, Bibel M, Régulier E, Bates GP, Paganetti P. J Neurochem; 2008 Feb 30; 104(3):846-58. PubMed ID: 17986219 [Abstract] [Full Text] [Related]
19. Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown. Cheng HM, Chern Y, Chen IH, Liu CR, Li SH, Chun SJ, Rigo F, Bennett CF, Deng N, Feng Y, Lin CS, Yan YT, Cohen SN, Cheng TH. PLoS Genet; 2015 Mar 30; 11(3):e1005043. PubMed ID: 25760041 [Abstract] [Full Text] [Related]
20. [Huntington disease. A review]. Bonilla E. Invest Clin; 2000 Jun 30; 41(2):117-41. PubMed ID: 10961047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]